Suxia Lin

1.8k citations

57 papers · 1.2k indexed · h-index 14

Impact in

Hepatology top 2%
- Hepatitis C virus research
Behavioral Neuroscience top 10%

Papers in ⓘ

Oncology 27
- Viral-associated cancers and disorders 12
- Vascular Tumors and Angiosarcomas 4
- Lung Cancer Research Studies 4
Pathology and Forensic Medicine 23
- Lymphoma Diagnosis and Treatment 20

Co-authors: Robert H. Pietrzak (1 shared paper)Shih‐Sung Chuang (1 shared paper)Marc N. Potenza (1 shared paper)Marc D. Normandin (1 shared paper)Yiyun Huang (1 shared paper)Dennis W. Raisch (1 shared paper)Steven M. Belknap (1 shared paper)M.-S. Dai (1 shared paper)
Journals: Blood (2 papers)Journal of Clinical Oncology (2 papers)Acta Pharmaceutica Sinica B (1 paper)Scientific Reports (1 paper)Nature Medicine (1 paper)
Partner nations: China United States Hong Kong

In The Last Decade

Suxia Lin

55 papers receiving 1.2k citations

Peers

Countries citing papers authored by Suxia Lin

Since Specialization

Citations

This map shows the geographic impact of Suxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Lin more than expected).

Fields of papers citing papers by Suxia Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Lin. The network helps show where Suxia Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Suxia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suxia Lin Line = papers co-authored together Suxia Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study Molecular Psychiatry ·A Neumeister, Marc D. Normandin, Robert H. Pietrzak, Daniele Piomelli, M. Zheng, A Gujarro-Anton, Marc N. Potenza, C R Bailey, Suxia Lin, Soheila Najafzadeh, Jim Ropchan, S. Henry, Stefani Corsi-Travali, Richard E. Carson, Yiyun Huang	2013	261
2	Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports Annals of Oncology ·Andrew M. Evens, Borko Jovanovic, Yu‐Chieh Su, Dennis W. Raisch, Daniel Ganger, Steven M. Belknap, M.-S. Dai, B.-C. C. Chiu, Bara Fintel, Yijun Cheng, Shih‐Sung Chuang, M.-Y. Lee, T.-Y. Chen, Suxia Lin, Ching‐Yuan Kuo	2010	256
3	Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy JAMA ·He Huang, Xueying Li, Jun Zhu, Sheng Ye, Hongyu Zhang, Wei Wang, Xiangyuan Wu, Jiewen Peng, Bing Xu, Yingcheng Lin, Yabing Cao, Haoran Li, Suxia Lin, Qing Liu, Tongyu Lin	2014	166
4	Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma American Journal of Clinical Oncology ·Yongbin Lin, Han Yang, Qingqing Cai, Daofeng Wang, Hui‐Lan Rao, Suxia Lin, Hao Long, Jianhua Fu, Lanjun Zhang, Peng Lin, Guangchuan Xu, Tiehua Rong, Xiaoxing Xiong, Guowei Ma, Ying Liang	2014	79
5	The Reproductive Toxicity of CdSe/ZnS Quantum Dots on the in vivo Ovarian Function and in vitro Fertilization Scientific Reports ·Gaixia Xu, Guimiao Lin, Suxia Lin, Na Wu, Yueyue Deng, Gang Feng, Qiang Chen, Junle Qu, Danni Chen, Siping Chen, Hanben Niu, Shujiang Mei, Ken‐Tye Yong, Xiaomei Wang	2016	50
6	Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma Nature Medicine ·Haijun Wen, Huajuan Ma, Qichun Cai, Suxia Lin, Xinxing Lei, Bin He, Sijin Wu, Zifeng Wang, Yan Gao, Wensheng Liu, Weiping Liu, Qian Tao, Zi‐Jie Long, Min Yan, Dali Li, Keith W. Kelley, Yongliang Yang, Huiqiang Huang, Quentin Liu	2018	49
7	Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. PubMed ·Zhi Li, Yi Ren, Qichang Wu, Suxia Lin, Ying-jie Liang, Huizhen Liang	2004	35
8	A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer Journal of Neuro-Oncology ·Ling Cai, Jianfei Zhu, Xuewen Zhang, Suxia Lin, Xiaodong Su, Peng Lin, Kai Chen, Lanjun Zhang	2014	34
9	The Invasion and Reproductive Toxicity of QDs-Transferrin Bioconjugates on Preantral Follicle in vitro Theranostics ·Gaixia Xu, Suxia Lin, Wing‐Cheung Law, Indrajit Roy, Xiaotan Lin, Shujiang Mei, Hanwu Ma, Siping Chen, Hanben Niu, Xiaomei Wang	2012	25
10	PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma Acta Pharmaceutica Sinica B ·Min Luo, Yuhui Xia, Fang Wang, Hong Zhang, Danting Su, Chaoyue Su, Chuan Yang, Shaocong Wu, Sainan An, Suxia Lin, Liwu Fu	2021	24
11	Endometrial Stromal Sarcoma Arising from Endometriosis: A Clinicopathological Study and Literature Review Gynecologic and Obstetric Investigation ·Chunyan Lan, Xin Huang, Suxia Lin, Muyan Cai, Jihong Liu	2012	16
12	Multifunctional Mesoporous Silica-Coated Gold Nanorods Mediate Mild Photothermal Heating-Enhanced Gene/Immunotherapy for Colorectal Cancer Pharmaceutics ·Meirong Li, Jingyu Yang, Xinhuang Yao, Xiang Li, Zhourui Xu, Shiqi Tang, Bangxu Sun, Suxia Lin, Chengbin Yang, Jia Liu	2023	14
13	Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion CHEST Journal ·Run-Bin Liang, Li Peng, Bob T. Li, Jietian Jin, Valerie W. Rusch, David R. Jones, Yi‐Long Wu, Qing Liu, Jie Yang, Mu‐Zi Yang, Shuo Li, Hao Long, Fu J, Lanjun Zhang, Peng Lin, Tiehua Rong, Xue Hou, Suxia Lin, Hao‐Xian Yang	2021	14
14	Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study Lipids in Health and Disease ·Fan Luo, Kangmei Zeng, Jiaxin Cao, Ting Zhou, Suxia Lin, Wenjuan Ma, Yunpeng Yang, Zhonghan Zhang, Feiteng Lu, Yan Huang, Hongyun Zhao, Li Zhang	2021	13
15	Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study Leukemia & lymphoma ·Huangming Hong, Xiaojie Fang, Zhao Wang, He Huang, Sio Teng Lam, Fangfang Li, Peng Chen, Ying Tian, Suxia Lin, Tongyu Lin	2018	13
16	Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma. PubMed ·Shi‐Juan Mai, Yong‐sheng Zong, Min Zhang, Bi‐ling Zhong, Suxia Lin	2002	13
17	Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumors. PubMed ·Xue Hou, Suxia Lin, Yongdong Liu, Kaicheng Wang, Zicheng Yu, Junhao Jia, Juan Yu, Wei Zheng, Jing Bai, Lianpeng Chang, Jing Chen, Meichen Li, Likun Chen	2022	13
18	Clinicopathologic features of primary lymphoma in soft tissue Leukemia & lymphoma ·Jing Yang, Fenfen Zhang, Hui-qiong Fang, Ziyin Ye, Suxia Lin, Anjia Han	2010	11
19	[Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance]. PubMed ·Zhi Li, Suxia Lin, Huizhen Liang, Jiehua He	2005	9
20	Overexpression of human telomerase reverse transcriptase C-terminal polypeptide sensitizes HeLa cells to 5-fluorouracil-induced growth inhibition and apoptosis Molecular Medicine Reports ·Guimiao Lin, Qiang Chen, Shuihong Yu, Suxia Lin, Hong Yao, Zhangchi Ding, Siping Chen, Marie C.M. Lin, Xiaomei Wang	2013	8

About Suxia Lin

Suxia Lin is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (12 papers), Immune Cell Function and Interaction (5 papers), Lung Cancer Treatments and Mutations (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Lung Cancer Research Studies (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and T-cell and Retrovirus Studies (4 papers). The work is most often cited by research in Hepatology (306 citations), Behavioral Neuroscience (51 citations), Biological Psychiatry (33 citations), Oncology (349 citations) and Pharmacology (208 citations). Suxia Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Robert H. Pietrzak, Shih‐Sung Chuang, Marc N. Potenza, Marc D. Normandin, Yiyun Huang, Dennis W. Raisch, Steven M. Belknap, M.-S. Dai, Borko Jovanovic and M. Zheng. Their work appears in journals such as Blood, Journal of Clinical Oncology, Acta Pharmaceutica Sinica B, Scientific Reports and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact